Search

everythinglearnresearchcommunity

for

Search:↓

User has seborrhoeic dermatitis causing hair loss. They are using Ketoconazole shampoo and may use selenium sulfide shampoo.

A user's transformation due to their efforts in fighting hair loss, which was achieved without a hair transplant; the discussion includes advice about treatments such as minoxidil and finasteride.

A user shared their experience with a hair transplant surgery in India, involving 3,500 grafts, and expressed satisfaction with the results and cost. The post received mixed reactions, with some users questioning the authenticity of the graft count and results, while others praised the outcome.

The user is using RU58841, Revivogen, Regenepure ketoconazole shampoo, and plans to use a stimufield cap to address hair loss. They aim to avoid finasteride and minoxidil while hoping to stop hair loss and regrow hair.

The conversation discusses the potential of GT20029 to stop hair loss and possibly regrow hair, considering the body's regenerative abilities. No specific treatments were mentioned due to the original post being removed.

RU58841 is not FDA approved, and users are discussing its availability and legitimacy in India, with some mentioning brands like Vantanex and Capomil. One user warns about the risk of gyno from RU58841, advising to stop use at the first sign of sensitivity.

A user switched from finasteride to dutasteride and experienced continuous shedding but is now seeing some regrowth. Others shared similar experiences, noting that shedding can continue but hair often improves over time with dutasteride.

A 21-year-old male experienced significant hair regrowth over a year using dutasteride, minoxidil, and ketoconazole shampoo. He noted improvements despite irregular application and mentioned that his hair is now thicker, with a previously bald spot completely gone.

A 57-year-old user shared their one-year hair loss treatment progress using Minoxidil, Finasteride, Dutasteride, RU58841, KX-826, Keto shampoo, vitamins, and an iRestore helmet. They are considering simplifying their regimen to prescribed medications and feel uncertain about continuing despite seeing some progress.

Chinese company gets green light for Pyrilutamide Phase II trial for androgenetic alopecia. Androgen receptors downregulate in androgen deficient environments.